Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function

Clinical Cardiology

Volumn 36, Issue 10, 2013, Pages 611-620

  Mccullough, Peter A ^a,b,c,d,e   Barnard, Denise ^f   Clare, Robert ^g   Ellis, Stephen J ^g   Fleg, Jerome L ^h   Fonarow, Gregg C ⁱ   Franklin, Barry A ^j   Kilpatrick, Ryan D ^k   Kitzman, Dalane W ^l   O'Connor, Christopher M ^g   Piña, Ileana L ^m   Thadani, Udho ⁿ   Thohan, Vinay ^l   Whellan, David J ^o  

^a St John Providence Health System   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^c St John Macomb Oakland Hospital   (United States)

^d PROVIDENCE HOSPITAL   (United States)

^e Providence Park Heart Institute   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^h NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^k AMGEN INC   (United States)

^l WAKE FOREST BAPTIST HEALTH   (United States)

^m ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁿ UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^o THOMAS JEFFERSON UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; HEMOGLOBIN; LOOP DIURETIC AGENT; NITRATE; SPIRONOLACTONE;

ADULT; AGED; AGING; ANEMIA; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; HYPERTENSION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BIOLOGICAL MARKERS; DISEASE PROGRESSION; EXERCISE THERAPY; FEMALE; HEART FAILURE; HEMOGLOBINS; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SYSTOLE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84885479636     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22181     Document Type: Article

References (36)

1. McCullough PA, Philbin EF, Spertus JA, et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) Study. J Am Coll Cardiol. 2002; 39: 60-69.
2. Szczech LA, Harmon W, Hostetter TH, et al. World Kidney Day 2009: problems and challenges in the emerging epidemic of kidney disease. J Am Soc Nephrol. 2009; 20: 453-455.
3. Whaley-Connell AT, Sowers JR, Stevens LA, et al. Kidney Early Evaluation Program Investigators. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008; 51 (4 suppl 2): S13-S20.
4. Whaley-Connell AT, Sowers JR, McFarlane SI, et al. Kidney Early Evaluation Program Investigators. Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008; 51 (4 suppl 2): S21-S29.
5. Artham SM, Lavie CJ, Patel HM, et al. Impact of obesity on the risk of heart failure and its prognosis. J Cardiometab Syndr. 2008; 3: 155-161.
6. Zalesin KC, Franklin BA, Miller WM, et al. Impact of obesity on cardiovascular disease. Endocrinol Metab Clin North Am. 2008; 37: 663-684.
7. McFarlane SI, Chen SC, Whaley-Connell AT, et al.; Kidney Early Evaluation Program Investigators. Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008 Apr; 51 (4 Suppl 2): S46-55.
8. Wu AH, Omland T, Wold Knudsen C, et al. Breathing Not Properly Multinational Study Investigations. Relationship of B-type natriuretic peptide and anemia in patients with and without heart failure: a substudy from the Breathing Not Properly (BNP) Multinational Study. Am J Hematol. 2005; 80: 174-180.
9. Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006; 47: 1987-1996.
10. McCullough PA, Lepor NE,. Piecing together the evidence on anemia: the link between chronic kidney disease and cardiovascular disease. Rev Cardiovasc Med. 2005;(6 suppl 3): S4-S12.
11. Anand I, McMurray JJ, Whitmore J, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation. 2004; 110: 149-154.
12. Whellan DJ, O'Connor CM, Lee KL, et al. HF-ACTION Trial Investigators. Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. Am Heart J. 2007; 153: 201-211.
13. O'Connor CM, Whellan DJ, Lee KL, et al. HF-ACTION Investigators. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009; 301: 1439-1450.
14. de Benoist B, McLean E, Egli I, et al, eds. Worldwide Prevalence of Anaemia, 1993-2005. Geneva, Switzerland: World Health Organization; 2008.
15. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130: 461-470.
16. McCullough PA, Franklin BA, Leifer E, et al. Impact of reduced kidney function on cardiopulmonary fitness in patients with systolic heart failure. Am J Nephrol. 2010; 32: 226-233.
17. McCullough PA, Lepor NE,. The deadly triangle of anemia, renal insufficiency, and cardiovascular disease: implications for prognosis and treatment. Rev Cardiovasc Med. 2005; 6: 1-10.
18. von Haehling S, van Veldhuisen DJ, Roughton M, et al. Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study. Eur J Heart Fail. 2011; 13: 656-663.
19. Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, et al. JCARECARD Investigators. Anemia is an independent predictor of long-term adverse outcomes in patients hospitalized with heart failure in Japan: a report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARECARD). Circ J. 2009; 73: 1901-1908.
20. Ronco C, McCullough P, Anker SD, et al. for the Acute Dialysis Quality Initiative (ADQI) consensus group. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur Heart J. 2010; 31: 703-711.
21. Weisensee D, Schnaars Y, Schoeppe W, et al. Potential uremic toxins modulate energy metabolism of cardiac myocytes in vitro. Exp Nephrol. 1997; 5: 194-200.
22. Yerkey MW, Kernis SJ, Franklin BA, et al. Renal dysfunction and acceleration of coronary disease. Heart. 2004; 90: 961-966.
23. Kato A., Increased hepcidin-25 and erythropoietin responsiveness in patients with cardio-renal anemia syndrome. Future Cardiol. 2010; 6: 769-771.
24. Smith K, Semple D, Bhandari S, et al. Cellular basis of uraemic cardiomyopathy: a role for erythropoietin? Eur J Heart Fail. 2009; 11: 732-738.
25. van der Zee S, Baber U, Elmariah S, et al. Cardiovascular risk factors in patients with chronic kidney disease. Nat Rev Cardiol. 2009; 6: 580-589.
26. Kovesdy CP, Kalantar-Zadeh K,. Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease. Nephrology (Carlton). 2009; 14: 408-415.
27. Hawkins S, Wiswell R,. Rate and mechanism of maximal oxygen consumption decline with aging: implications for exercise training. Sports Med. 2003; 33: 877-888.
28. Herzog CA, Muster HA, Li S, et al. Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. J Card Fail. 2004; 10: 467-472.
29. Anderson S, Halter JB, Hazzard WR, et al. workshop participants. Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol. 2009; 20: 1199-1209.
30. Shlipak MG, Katz R, Kestenbaum B, et al. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis. 2009; 204: 298-303.
31. Franklin BA,. Survival of the fittest: evidence for high-risk and cardioprotective fitness levels. Curr Sports Med Rep. 2002; 1: 257-259.
32. McCullough PA,. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? J Am Coll Cardiol. 2003; 41: 725-728.
33. Stenvinkel P, Carrero JJ, Axelsson J, et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol. 2008; 3: 505-521.
34. Schisterman EF, Cole SR, Platt RW,. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009; 20: 488-495.
35. O'Connor CM, Whellan DJ, Wojdyla D, et al. Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model. Circ Heart Fail. 2012; 5: 63-71.
36. Enders CK,. Applied Missing Data Analysis. New York, NY: Guilford Press; 2010.